SS Innovations International (NASDAQ:SSII) Trading Down 8.2% – Should You Sell?

SS Innovations International, Inc. (NASDAQ:SSII)’s share price traded down 8.2% during mid-day trading on Wednesday . The stock traded as low as $4.42 and last traded at $4.39. 47,332 shares were traded during mid-day trading, a decline of 48% from the average session volume of 90,546 shares. The stock had previously closed at $4.78.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of SS Innovations International in a report on Thursday, January 22nd. One analyst has rated the stock with a Sell rating, According to data from MarketBeat, SS Innovations International has a consensus rating of “Sell”.

SS Innovations International Stock Down 10.0%

The firm’s fifty day moving average price is $4.55 and its two-hundred day moving average price is $5.83. The stock has a market capitalization of $861.00 million and a PE ratio of -71.67.

SS Innovations International (NASDAQ:SSII) last released its quarterly earnings data on Tuesday, March 10th. The company reported ($0.01) earnings per share for the quarter. SS Innovations International had a negative net margin of 28.54% and a negative return on equity of 30.23%. The company had revenue of $14.53 million for the quarter.

Insider Activity

In other SS Innovations International news, Director Timothy P. Adams bought 300,000 shares of the business’s stock in a transaction that occurred on Friday, March 6th. The stock was bought at an average cost of $3.99 per share, for a total transaction of $1,197,000.00. Following the completion of the transaction, the director owned 5,331,902 shares of the company’s stock, valued at $21,274,288.98. This represents a 5.96% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Srivastava Sudhir bought 498,753 shares of the business’s stock in a transaction that occurred on Friday, March 6th. The shares were acquired at an average price of $4.01 per share, with a total value of $1,999,999.53. Following the completion of the transaction, the chief executive officer directly owned 109,851,767 shares of the company’s stock, valued at $440,505,585.67. This trade represents a 0.46% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders purchased 1,300,006 shares of company stock valued at $5,196,999 over the last three months.

Institutional Trading of SS Innovations International

Several large investors have recently added to or reduced their stakes in SSII. Geode Capital Management LLC bought a new stake in SS Innovations International during the second quarter valued at approximately $122,000. Inspire Investing LLC bought a new stake in SS Innovations International during the third quarter valued at approximately $240,000. Envestnet Asset Management Inc. bought a new stake in SS Innovations International during the third quarter valued at approximately $71,000. PNC Financial Services Group Inc. bought a new stake in SS Innovations International during the third quarter valued at approximately $56,000. Finally, Handelsbanken Fonder AB bought a new stake in SS Innovations International during the third quarter valued at approximately $714,000.

SS Innovations International Company Profile

AVRA Medical Robotics, Inc develops and manufactures medical surgical devices. The company has a research agreement with the University of Central Florida to develop navigation and control technologies with applications in medical robotics. The company was formerly known as AVRA Surgical Microsystems, Inc and changed its name to AVRA Medical Robotics, Inc in November 2015. AVRA Medical Robotics, Inc was founded in 2015 and is based in Orlando, Florida.